Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Oesophago-gastric Cancer × Epirubicin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 125 Stomach Neoplasms 20 Triple Negative Breast Neoplasms 17 Inflammatory Breast Neoplasms 12 Carcinoma, Hepatocellular 12 Esophageal Neoplasms 10 Lymphoma, Large B-Cell, Diffuse 6 Pancreatic Neoplasms 4 Neoplasms 4 Urinary Bladder Neoplasms 3 Testicular Neoplasms 3 Sarcoma 3 Primary Breast Cancer 3 Gallbladder Neoplasms 3 Carcinoma, Ductal, Breast 3 Adenocarcinoma Of Esophagus 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pathologic Complete Response 2 Non-Muscle Invasive Bladder Neoplasms 2 Neoplasms, Germ Cell and Embryonal 2 Liver Neoplasms 2 Breast Neoplasms, Male 2 Breast Diseases 2 Women With Primary Breast Cancer 1 Wilms Tumor 1 Upper Tract Urothelial Carcinoma 1 Thymoma 1 Testicular Germ Cell Tumor 1

Interventions

Panitumumab 1 Oxaliplatin 1 Epirubicin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00824785 2012-12-11

REAL3

Royal Marsden NHS Foundation Trust

Phase 3 Terminated

Gastrointestinal

Oesophago-gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡